Microbix Financial Statements From 2010 to 2024

Stocks Canada . 
Stock . Microbix Biosystems
MBX Stock  CAD 0.31  0.01  3.13%   
Microbix Biosystems financial statements provide useful quarterly and yearly information to potential Microbix Biosystems investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Microbix Biosystems financial statements helps investors assess Microbix Biosystems' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Microbix Biosystems' valuation are summarized below:
Gross Profit
11.1 M
Profit Margin
0.2173
Market Capitalization
42.4 M
Enterprise Value Revenue
1.5084
Revenue
23.4 M
We have found one hundred twenty available fundamental ratios for Microbix Biosystems, which can be analyzed and compared to other ratios and to its peers in the industry. Self-guided Investors are advised to check Microbix Biosystems' last-minute fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 2nd of December 2024, Market Cap is likely to drop to about 22.1 M. In addition to that, Enterprise Value is likely to drop to about 24.1 M

Microbix Biosystems Total Revenue

19.94 Million

Check Microbix Biosystems financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbix Biosystems' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 540.3 K or Selling General Administrative of 7.9 M, as well as many indicators such as Price To Sales Ratio of 5.07, Dividend Yield of 0.0 or PTB Ratio of 1.9. Microbix financial statements analysis is a perfect complement when working with Microbix Biosystems Valuation or Volatility modules.
  
This module can also supplement various Microbix Biosystems Technical models . Check out the analysis of Microbix Biosystems Correlation against competitors.

Microbix Biosystems Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets43.1 M41 M24.3 M
Slightly volatile
Short and Long Term Debt Total4.5 M7.6 M6.1 M
Slightly volatile
Total Current Liabilities2.7 M5 M3.8 M
Slightly volatile
Total Stockholder Equity29.7 M28.3 M15 M
Slightly volatile
Property Plant And Equipment Net5.8 M10.3 M8 M
Pretty Stable
Accounts Payable1.5 M2.4 M1.8 M
Pretty Stable
Cash14 M13.3 M4.7 M
Slightly volatile
Non Current Assets Total9 M15.4 M12.4 M
Pretty Stable
Cash And Short Term Investments14 M13.3 M4.7 M
Slightly volatile
Net Receivables5 M4.8 M2.5 M
Slightly volatile
Common Stock Shares Outstanding166.5 M158.6 M102 M
Slightly volatile
Liabilities And Stockholders Equity43.1 M41 M24.3 M
Slightly volatile
Inventory6.9 M6.6 M3.9 M
Slightly volatile
Other Current Assets926.7 K882.6 K380 K
Slightly volatile
Other Stockholder Equity11.5 M11.8 M9 M
Slightly volatile
Total Liabilities6.5 M12.7 M8.8 M
Slightly volatile
Property Plant And Equipment Gross21 M20 M11.2 M
Slightly volatile
Total Current Assets26.9 M25.6 M11.4 M
Slightly volatile
Short Term Debt290 K305.2 K1.2 M
Pretty Stable
Non Current Liabilities Total4 M7.7 M5.1 M
Slightly volatile
Intangible Assets3.5 M5.1 M3.9 M
Very volatile
Common Stock Total Equity31.8 M40.7 M31.4 M
Slightly volatile
Common Stock35.8 M56.4 M35.1 M
Slightly volatile
Other Liabilities330.1 K371.4 K404.4 K
Slightly volatile
Net Tangible Assets28.3 M27 M12.3 M
Slightly volatile
Long Term Debt3.8 M5.1 M4.8 M
Slightly volatile
Short and Long Term Debt95 K100 K1.2 M
Pretty Stable
Property Plant Equipment7.4 M8 M8.9 M
Slightly volatile
Long Term Debt Total5.5 M6.4 M5.3 M
Very volatile
Capital Surpluse9.2 M11.1 M7.6 M
Slightly volatile
Capital Lease Obligations589.3 K982.1 K394.7 K
Slightly volatile
Net Invested Capital24.1 M35 M23.1 M
Slightly volatile
Capital Stock45.1 M56.4 M39 M
Slightly volatile
Non Current Liabilities Other239 K268.8 K292.7 K
Slightly volatile

Microbix Biosystems Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.4 M1.3 M699.2 K
Slightly volatile
Selling General Administrative7.9 M7.5 M3.9 M
Slightly volatile
Total Revenue19.9 M19 M12.2 M
Slightly volatile
Gross Profit4.4 M8.6 M5.9 M
Slightly volatile
Other Operating Expenses23.2 M22.1 M12.2 M
Slightly volatile
Research Development2.5 M2.4 M1.2 M
Slightly volatile
Cost Of Revenue10.9 M10.4 M6 M
Slightly volatile
Total Operating Expenses12.3 M11.8 M6.1 M
Slightly volatile
Selling And Marketing Expenses784.7 K1.3 M930.9 K
Very volatile
Reconciled Depreciation860.3 K1.3 M715.1 K
Slightly volatile

Microbix Biosystems Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow16.3 M15.5 M3.8 M
Slightly volatile
Depreciation1.4 M1.3 M699.2 K
Slightly volatile
Capital Expenditures1.1 M1.2 M1.4 M
Very volatile
End Period Cash Flow14 M13.3 M4.7 M
Slightly volatile
Stock Based Compensation887.9 K845.6 K433.3 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.072.983.2924
Pretty Stable
PTB Ratio1.92.02.6388
Pretty Stable
Days Sales Outstanding83.1910675.0625
Very volatile
Book Value Per Share0.0880.160.1416
Very volatile
Average Payables992 K1.5 M1.6 M
Very volatile
Stock Based Compensation To Revenue0.03520.05120.0345
Very volatile
Capex To Depreciation0.750.792.6695
Slightly volatile
PB Ratio1.92.02.6388
Pretty Stable
EV To Sales2.52.633.3159
Slightly volatile
Inventory Turnover2.191.811.7706
Pretty Stable
Days Of Inventory On Hand287267350
Slightly volatile
Payables Turnover2.063.912.9653
Slightly volatile
Sales General And Administrative To Revenue0.360.450.327
Very volatile
Average Inventory5.2 M5 M3.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.250.140.1185
Very volatile
Capex To Revenue0.06720.07080.1308
Slightly volatile
Cash Per Share0.10.09680.0451
Pretty Stable
Days Payables Outstanding18196.66144
Slightly volatile
Intangibles To Total Assets0.150.110.1796
Slightly volatile
Current Ratio2.975.93.0647
Slightly volatile
Tangible Book Value Per Share0.140.130.1047
Pretty Stable
Receivables Turnover4.283.565.2529
Very volatile
Graham Number0.03710.0390.1747
Pretty Stable
Shareholders Equity Per Share0.0880.160.1416
Very volatile
Debt To Equity0.20.210.5383
Slightly volatile
Capex Per Share0.01260.00660.0154
Pretty Stable
Average Receivables3.4 M3.3 M2.2 M
Slightly volatile
Revenue Per Share0.0880.110.1173
Pretty Stable
Interest Debt Per Share0.05060.04330.0732
Slightly volatile
Debt To Assets0.220.150.2753
Slightly volatile
Operating Cycle378373329
Very volatile
Price Book Value Ratio1.92.02.6388
Pretty Stable
Days Of Payables Outstanding18196.66144
Slightly volatile
Ebt Per Ebit0.01230.0132.5771
Pretty Stable
Company Equity Multiplier1.491.31.7856
Slightly volatile
Long Term Debt To Capitalization0.230.170.2792
Slightly volatile
Total Debt To Capitalization0.260.170.3205
Slightly volatile
Debt Equity Ratio0.20.210.5383
Slightly volatile
Quick Ratio4.594.382.2862
Slightly volatile
Net Income Per E B T0.860.95861.0741
Very volatile
Cash Ratio3.223.071.4715
Slightly volatile
Cash Conversion Cycle173277175
Slightly volatile
Days Of Inventory Outstanding287267350
Slightly volatile
Days Of Sales Outstanding83.1910675.0625
Very volatile
Price To Book Ratio1.92.02.6388
Pretty Stable
Fixed Asset Turnover1.932.131.6493
Pretty Stable
Debt Ratio0.220.150.2753
Slightly volatile
Price Sales Ratio5.072.983.2924
Pretty Stable
Asset Turnover0.690.530.5268
Slightly volatile
Gross Profit Margin0.630.520.5377
Pretty Stable
Price Fair Value1.92.02.6388
Pretty Stable

Microbix Biosystems Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap22.1 M38.5 M32.2 M
Slightly volatile
Enterprise Value24.1 M34 M34.9 M
Slightly volatile

Microbix Fundamental Market Drivers

Forward Price Earnings15.2439
Cash And Short Term Investments11.6 M

About Microbix Biosystems Financial Statements

Microbix Biosystems investors utilize fundamental indicators, such as revenue or net income, to predict how Microbix Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue2.3 M2.4 M
Total Revenue19 M19.9 M
Cost Of Revenue10.4 M10.9 M
Stock Based Compensation To Revenue 0.05  0.04 
Sales General And Administrative To Revenue 0.45  0.36 
Research And Ddevelopement To Revenue 0.14  0.25 
Capex To Revenue 0.07  0.07 
Revenue Per Share 0.11  0.09 
Ebit Per Revenue(0.15)(0.16)

Pair Trading with Microbix Biosystems

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbix Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbix Biosystems will appreciate offsetting losses from the drop in the long position's value.

Moving against Microbix Stock

  0.85AMZN Amazon CDRPairCorr
  0.8NVDA NVIDIA CDRPairCorr
  0.77BOFA Bank of AmericaPairCorr
  0.76TD-PFD Toronto Dominion Bank Earnings Call This WeekPairCorr
  0.71GOOG Alphabet CDRPairCorr
The ability to find closely correlated positions to Microbix Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbix Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbix Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbix Biosystems to buy it.
The correlation of Microbix Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbix Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbix Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microbix Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Microbix Stock

Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Financial
Indicators
Details
Valuation
Indicators
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY